Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: Which differences are clinically important?
Open Access
- 1 January 2012
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 10 (1) , 79
Abstract
Development of new tinnitus treatments requires prospective placebo-controlled randomized trials to prove their efficacy. The Tinnitus Questionnaire (TQ) is a validated and commonly used instrument for assessment of tinnitus severity and has been used in many clinical studies. Defining the Minimal Clinically Important Difference (MCID) for TQ changes is an important step to a better interpretation of the clinical relevance of changes observed in clinical trials. In this study we aimed to estimate the minimum change of the TQ score that could be considered clinically relevant. 757 patients with chronic tinnitus were pooled from the TRI database and the RESET study. An anchor-based approach using the Clinical Global Impression (CGI) scale and distributional approaches were used to estimate MCID. Receiver Operating Characteristic (ROC) curves were calculated to define optimal TQ change cutoffs discriminating between minimally changed and unchanged subjects. The relationship between TQ change scores and CGI ratings of change was good (r = 0.52, p < 0.05). Mean change scores associated with minimally better and minimally worse CGI categories were −6.65 and +2.72 respectively. According to the ROC method MCID for improvement was −5 points and for deterioration +1 points. Distribution and anchor-based methods yielded comparable results in identifying MCIDs. ΔTQ scores of −5 and +1 points were identified as the minimal clinically relevant change for improvement and worsening respectively. The asymmetry of the MCIDs for improvement and worsening may be related to expectation effects.Keywords
This publication has 57 references indexed in Scilit:
- Systematic review and meta‐analyses of randomized controlled trials examining tinnitus managementThe Laryngoscope, 2011
- A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitusBMC Ear, Nose and Throat Disorders, 2011
- The Tinnitus Research Initiative (TRI) database: A new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcomeBMC Medical Informatics and Decision Making, 2010
- Tinnitus Intensity Dependent Gamma Oscillations of the Contralateral Auditory CortexPLOS ONE, 2009
- Abnormal resting-state cortical coupling in chronic tinnitusBMC Neuroscience, 2009
- Design of a placebo-controlled, randomized study of the efficacy of repetitive transcranial magnetic stimulation for the treatment of chronic tinnitusBMC Psychiatry, 2008
- Tinnitus Perception and Distress Is Related to Abnormal Spontaneous Brain Activity as Measured by MagnetoencephalographyPLOS Medicine, 2005
- Central tinnitusAuris Nasus Larynx, 2003
- Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue ScalesJournal of Pain and Symptom Management, 2002
- Measurement of health statusControlled Clinical Trials, 1989